Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Direct angiotensin AT2-receptor stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Alemtuzumab (Lemtrada) - NICE says yes in final draft guidance
PLEGRIDY™ (peginterferon beta-1a) approved in the European Union for the treatment of multiple sclerosis
Is it time for a new global classification of multiple sclerosis?
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis.
Laquinimod Halted MS Disability But Not Relapses
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Substance Name: Dronabinol
MiR-126: a novel route for natalizumab action?
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.
mfERG_LAB: Software for processing multifocal electroretinography signals.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Multiple sclerosis: Does aggressive MS warrant aggressive treatment?
Neuroprotective effects of riluzole in neurotrauma models: a review.

Pages